Trials / Recruiting
RecruitingNCT05479305
Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Ceric Sàrl · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study objectives are to assess safety and effectiveness, measured acutely and at the 30-day visit after implantation of the Valiant Captivia physician fenestrated Stent Graft. Clinical utility measures throughout the procedure and until discharge will be assessed
Detailed description
Prospective, single-arm, non-randomised, multicenter, investigator initiated clinical study evaluating subjects implanted with The Valiant Captivia physician fenestrated stent graft for the treatment of aneurysms/penetrating ulcers, Type B aortic dissections or residual dissection after Type A repair, of the aortic arch and the descending thoracic aorta which are candidates for revascularisation of all three supra-aortic vessels (BT (brachiocephalic trunk) , LCCA (left Common Carotid artery), LSA (Left Subclavian Artery)
Conditions
- Penetrating Ulcer of Aorta
- Aneurysm Aortic
- Type B Aortic Dissection
- Residual Dissection After Type A Repair
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The Valiant Captivia Stent Graft | Aortic arch/Descending aorta Repair |
Timeline
- Start date
- 2023-11-21
- Primary completion
- 2024-11-01
- Completion
- 2027-10-01
- First posted
- 2022-07-29
- Last updated
- 2024-05-01
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05479305. Inclusion in this directory is not an endorsement.